Dementia, quantitative neuroimaging, and apolipoprotein E genotype.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  AJNR. American journal of neuroradiology

• Publication date

  2000-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 11110538PMCID PMC7974277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aging of the brain and its impact on cognitive performance: Integration of structural and functional findings.

  2000cited by this paper
• APOE-ε4 is associated with memory decline in cognitively impaired elderly

  2000cited by this paper
• PRECLINICAL EVIDENCE OF ALZHEIMER’S DISEASE IN PERSONS HOMOZYGOUS FOR THE

  2000cited by this paper
• Dementia diagnoses from clinical and neuropsychological data compared

  2000cited by this paper
• MRI volumetric study of dementia with Lewy bodies

  2000cited by this paper
• Performance characteristics of a two-stage dementia screen in a population sample.

  2000cited by this paper
• APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome

  1999cited by this paper
• Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

  1999cited by this paper
• The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

  1999cited by this paper
• A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age.

  1999cited by this paper
• Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias

  1999cited by this paper
• Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease

  1999cited by this paper
• APOE genotype as a risk factor for ischemic cerebrovascular disease

  1999cited by this paper
• Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

  1999influential reference
• Male Pseudohermaphroditism Related to Complications at Conception, in Early Pregnancy or in Prenatal Growth

  1999cited by this paper
• Mild cognitive impairment raises Alzheimer disease risk.

  1999cited by this paper
• MRI Temporal Lobe Volume Measures and Neuropsychologic Function in Alzheimer's Disease

  1999cited by this paper
• APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.

  1999cited by this paper
• Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease.

  1999cited by this paper
• APOE-ε4 count predicts age when prevalence of AD increases, then declines

  1999cited by this paper
• Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.

  1999cited by this paper
• Association of Angiotensin-Converting Enzyme Gene Polymorphism with Lipid Profiles in Children and Adolescents with Insulin-Dependent Diabetes mellitus

  1999cited by this paper
• Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease

  1999cited by this paper
• APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

  1999influential reference
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia

  1998cited by this paper
• Diagnostic challenges in dementia

  1998cited by this paper
• Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.

  1998cited by this paper
• Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer's disease.

  1998cited by this paper
• APOE genotype predicts when — not whether — one is predisposed to develop Alzheimer disease

  1998cited by this paper
• Alzheimer's disease

  1998cited by this paper
• Risk of Alzheimer Disease with the ±4 Allele for Apolipoprotein E in a Population‐Based Study of Men Aged 62–73 Years

  1998cited by this paper
• Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

  1998cited by this paper
• Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia.

  1998cited by this paper
• Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity.

  1998cited by this paper
• Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease

  1998cited by this paper
• A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval.

  1998cited by this paper
• Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins

  1998cited by this paper
• Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury.

  1998cited by this paper
• Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.

  1998cited by this paper
• Alpha-2 macroglobulin is genetically associated with Alzheimer disease

  1998cited by this paper
• MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices.

  1998cited by this paper
• Variation in hippocampal neuron number with age and brain volume.

  1998cited by this paper
• Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease.

  1998cited by this paper
• Cortical variability and asymmetry in normal aging and Alzheimer's disease.

  1998cited by this paper
• Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects

  1998cited by this paper
• Apolipoprotein E4 Promotes Incipient Alzheimer Pathology in the Elderly

  1998cited by this paper
• Apolipoprotein E Phenotypes, Dementia and Mortality in a Prospective Population Sample

  1998cited by this paper
• Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.

  1998cited by this paper
• Brain volume preserved in healthy elderly through the eleventh decade

  1998cited by this paper
• Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer's type.

  1998cited by this paper
• Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.

  1998cited by this paper
• Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease

  1998influential reference
• Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease

  1998influential reference
• Genetic studies on chromosome 12 in late-onset Alzheimer disease.

  1998cited by this paper
• Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

  1998cited by this paper
• Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.

  1998influential reference
• Alzheimer disease — when and why?

  1998cited by this paper
• Differences in neuropsychological functioning associated with age, education, neurological status, and magnetic resonance imaging findings in neurologically healthy elderly individuals.

  1998cited by this paper
• Clinicopathologic studies in cognitively healthy aging and Alzheimer disease

  1998cited by this paper
• Apolipoprotein E ε4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease

  1998cited by this paper
• Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.

  1997cited by this paper
• Hippocampal volume in normal aging and traumatic brain injury.

  1997cited by this paper
• Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition.

  1997cited by this paper
• Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia

  1997cited by this paper
• Quantitative MR volumetry in Alzheimer's disease

  1997cited by this paper
• ApoE-4 and Age at Onset of Alzheimer's Disease

  1997cited by this paper
• Apolipoprotein E ϵ4 allele and hippocampal volume in twins with normal cognition

  1997cited by this paper
• Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele.

  1997cited by this paper
• Alterations in apolipoprotein E expression during aging and neurodegeneration.

  1996cited by this paper
• Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein E and Alzheimer's disease.

  1996cited by this paper
• SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.

  1996cited by this paper
• The influence of white matter lesions on neuropsychological functioning in demented and non‐demented 85‐year‐olds

  1996cited by this paper
• Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

  1996cited by this paper
• A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment

  1996cited by this paper
• Apolipoprotein E, memory and Alzheimer's disease.

  1996cited by this paper
• Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease

  1996cited by this paper
• Apolipoprotein E, memory and Alzheimer's disease

  1996cited by this paper
• Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life.

  1995cited by this paper
• MRI-based hippocampal volumetrics: data acquisition, normal ranges, and optimal protocol.

  1995influential reference
• Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

  1995cited by this paper
• Apolipoprotein E and Alzheimer's disease

  1995cited by this paper
• Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ϵ4 allele

  1995cited by this paper
• Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes.

  1995cited by this paper
• Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

  1995cited by this paper
• Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease

  1995cited by this paper
• Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults

  1995cited by this paper
• The Prevalence of White-Matter Lesions on Computed Tomography of the Brain in Demented and Nondemented 85-Year-Olds

  1994cited by this paper
• Three dimensional biomedical imaging

  1994cited by this paper
• Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.

  1994cited by this paper
• Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

  1994cited by this paper
• "Association of apolipoprotein E allele !e4 with late-onset familial and sporadic Alzheimer's disease": Comment.

  1994cited by this paper
• Inverse association of anti‐inflammatory treatments and Alzheimer's disease

  1994cited by this paper
• New criteria for the diagnosis of vascular dementia

  1993cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

  1993cited by this paper
• Vascular dementia

  1993cited by this paper
• Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning.

  1991cited by this paper
• Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

  1991cited by this paper

• Scheltens rating scores of white matter are predictive of language function among older adults with dementia.

  2025cites this paper
• Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers

  2024cites this paper
• Functional Glial Activation Mediates Phenotypic Effects of APOEɛ4 and Sex in Alzheimer’s Disease

  2024cites this paper
• The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance

  2021influential citation
• Pharmacogenomic approaches to the treatment of sporadic Alzheimer’s disease

  2020cites this paper
• Vascular burden and APOE &egr;4 are associated with white matter microstructural decline in cognitively normal older adults

  2019cites this paper
• MRI Clinical Ratings and Cognitive Function in a Cross-Sectional Population Study of Dementia: The Cache County Memory Study

  2019cites this paper
• Apolipoprotein E polymorphism and hippocampal atrophy across the spectrum of Alzheimer’s disease and dementia with Lewy bodies

  2018influential citation
• Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.

  2017cites this paper
• Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer’s Disease

  2016cites this paper
• The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease

  2016cites this paper
• Distinct contribution of white matter damage to the clinical syndrome of Alzheimer's disease

  2016cites this paper
• Alzheimers Disease Current and Future Perspectives

  2016cites this paper
• Pharmacogenomic Approaches to the Treatment of Sporadic Alzheimer Disease using Cholinomimetic Agents

  2015cites this paper
• Analysis of intracranial volume ratios by means of cerebrospinal fluid deployment indicators.

  2015cites this paper
• Acute sports-related traumatic brain injury and repetitive concussion.

  2015cites this paper
• COMPUTERIZED TOOLS: A SUBSTITUTE OR A SUPPLEMENT WHEN DIAGNOSING ALZHEIMER'S DISEASE?

  2015cites this paper
• Traumatic brain injury and reserve.

  2015cites this paper
• Correlations between cerebellar and brain volumes, cognitive impairments, ApoE levels, and APOE genotypes in patients with AD and MCI.

  2013cites this paper
• Resting-State Network Disruption and APOE Genotype in Alzheimer's Disease: A lagged Functional Connectivity Study

  2012cites this paper
• Mapping the Alzheimer’s Brain with Connectomics

  2012cites this paper
• Spect cerebral, poliformismo del gen apoe y valoración neuropsicológica en la predicción de la evolución de los pacientes con deterioro cognitivo ligero a enfermedad de Alzheimer

  2012cites this paper
• Amygdala in Alzheimer's Disease

  2012cites this paper
• Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study

  2012cites this paper
• Midlife Motivational Abilities Predict Apathy and Depression in Alzheimer Disease: The Aging, Demographics, and Memory Study

  2011cites this paper
• Cerebral Volume Loss, Cognitive Deficit, and Neuropsychological Performance: Comparative Measures of Brain Atrophy: II. Traumatic Brain Injury

  2011cites this paper
• Apolipoprotein E Genotype is Associated with Temporal and Hippocampal Atrophy Rates in Healthy Elderly Adults: A Tensor-Based Morphometry Study

  2011cites this paper
• Intracranial volume and dementia: some evidence in support of the cerebral reserve hypothesis.

  2011cites this paper
• Altered default mode network connectivity in alzheimer's disease—A resting functional MRI and bayesian network study

  2011cites this paper
• Deriving difference between the Bayesian networks based patterns of the effective connectivity using permutation test in fMRI studies

  2010cites this paper
• CSF Levels of the Histamine Metabolite tele-Methylhistamine are only Slightly Decreased in Alzheimer's Disease

  2010cites this paper
• Cardiorespiratory Fitness and Preserved Medial Temporal Lobe Volume in Alzheimer Disease

  2009cites this paper
• Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon 4, and hyperhomocysteinemia in neurodegenerative dementias.

  2009cites this paper
• Impact of APOE on the Healthy Aging Brain: A Voxel-Based MRI and DTI Study

  2009cites this paper
• Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer ' s Disease

  2009cites this paper
• Quantifizierung regionaler Atrophie der grauen Substanz und des Corpus callosum bei Patienten mit Alzheimer Erkrankung und vaskulärer Demenz im Vergleich zu gesunden älteren Kontrollpersonen

  2009cites this paper
• Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

  2008cites this paper
• Regional atrophy of the corpus callosum in dementia

  2008cites this paper
• Clinical , neuropsychological testing , brain MRI and SPECT in Alzheimer and vascular dementia

  2008cites this paper
• Alzheimer-Krankheit und vaskuläre Demenz

  2008cites this paper
• Pharmacogenomics and the Treatment of Sporadic Alzheimers Disease:A Decade of Progress

  2008cites this paper
• MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.

  2008cites this paper
• Synergistic effect of apolipoprotein E ϵ4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

  2008cites this paper
• Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies

  2008cites this paper
• The apolipoprotein E ɛ4‐allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities

  2007cites this paper
• Knowledge-based localization of hippocampus in human brain MRI

  2007cites this paper
• Magnetic resonance imaging of Alzheimer’s disease

  2007cites this paper
• Autopsy-confirmed Alzheimer's disease versus clinically diagnosed Alzheimer's disease in the Cache County Study on Memory and Aging: A comparison of quantitative MRI and neuropsychological findings

  2007influential citation
• Imagerie par résonance magnétique spectroscopique et exploration neurochimique de régions cérébrales

  2007cites this paper
• Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve.

  2007influential citation
• Neuroimaging and APOE Genotype: A Systematic Qualitative Review

  2007cites this paper
• The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities.

  2007cites this paper
• Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.

  2007cites this paper
• The Honolulu-Asia Aging Study

  2007cites this paper
• Day-of-Injury Computerized Tomography, Rehabilitation Status, and Development of Cerebral Atrophy in Persons with Traumatic Brain Injury

  2006cites this paper
• Neuropsychological Markers of Progression From Mild Cognitive Impairment to Alzheimer’s Disease

  2006cites this paper
• The search for antecedent biomarkers of Alzheimer's disease

  2006cites this paper
• A Longitudinal Study of Closed Head Injury: Neuropsychological Outcome and Structural Analysis using Region of Interest Measurements and Voxel-Based Morphometry

  2005cites this paper
• Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.M400486-JLR200

  2005cites this paper
• Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly

  2005cites this paper
• Association between Global Brain Volume and the Rate of Cognitive Change in Elderly Humans without Dementia

  2005influential citation
• Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study

  2004cites this paper
• Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.

  2004cites this paper
• Effects of hypoxia on the brain: Neuroimaging and neuropsychological findings following carbon monoxide poisoning and obstructive sleep apnea

  2004cites this paper
• Influence of Apolipoprotein E ϵ4 Genotype on Brain Tissue Integrity in Relapsing-Remitting Multiple Sclerosis

  2004cites this paper
• Cerebral volume loss, cognitive deficit and neuropsychological performance: Comparative measures of brain atrophy: I. Dementia

  2004influential citation
• Preclinical Memory Profile in Alzheimer Patients with and without Allele APOE-epsilon4

  2004cites this paper
• Impact of APOE in mild cognitive impairment

  2004cites this paper
• [Imaging of mild cognitive impairment].

  2003cites this paper
• [Mild cognitive impairment: an unhelpful and even unnecessary concept].

  2003cites this paper
• Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging.

  2003cites this paper
• Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.

  2003cites this paper
• Accelerated Memory Decline in Alzheimer's Disease With Apolipoprotein ϵ4 Allele

  2003cites this paper
• Apolipoproteins E and C1 and brain morphology in memory impaired elders

  2003cites this paper
• Clinical Correlates of Cognitive Decline in Vascular Dementia

  2003cites this paper
• Transient ischaemic attacks are associated with increased rates of global cerebral atrophy

  2003cites this paper
• Dementia, asymmetry of temporal lobe structures, and Apolipoprotein E genotype: Relationships to cerebral atrophy and neuropsychological impairment

  2002influential citation
• White Matter Lesions, Quantitative Magnetic Resonance Imaging, and Dementia

  2002influential citation
• Temporal lobe morphology in normal aging and traumatic brain injury.

  2002cites this paper
• Traumatic brain injury and atrophy of the cingulate gyrus.

  2002cites this paper
• Gene action in the aging brain: an evolutionary biological perspective.

  2002cites this paper
• The effect of APOE &egr;4 allele on cerebral glucose metabolism in AD is a function of age at onset

  2002cites this paper
• The impact of a single mild traumatic brain injury on neurocognitive performance

  2002cites this paper
• Distinguished Neuropsychologist Award Lecture 1999. The lesion(s) in traumatic brain injury: implications for clinical neuropsychology.

  2001cites this paper
• Brain Volume, Intracranial Volume, and Dementia

  2001cites this paper
• Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.

  2000cites this paper
• Polysubstance abuse and traumatic brain injury: Quantitative magnetic resonance imaging and neuropsychological outcome in older adolescents and young adults

  1999cites this paper